A substantial advancement in glucose treatment is emerging with the introduction of tirzepatide at a dosage of 45mg. This updated offering builds upon the existing success of tirzepatide, a dual GIP and GLP-1 target, https://lewisqgtj923018.governor-wiki.com/2275111/groundbreaking_introduction_tirzepatide_dose_for_diabetes_management